<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="141376">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02092883</url>
  </required_header>
  <id_info>
    <org_study_id>25QNC</org_study_id>
    <nct_id>NCT02092883</nct_id>
  </id_info>
  <brief_title>Evaluation of Neuroinflammation in Children With Infantile Spasms</brief_title>
  <official_title>Neuroinflammation in Children With Infantile Spasms Measured With 11C-PK11195 Positron Emission Tomography: Response to ACTH</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wayne State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wayne State University</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to investigate the presence of neuroinflammation in children
      with infantile spasms using 11C-PK11195 positron emission tomography (PK PET) scan, and its
      response to ACTH treatment by repeating the PK PET scan after treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Neuroinflammation in cortical and/or subcortical structures</measure>
    <time_frame>up to 6 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Neuroinflammation in cortical and/or subcortical structures of the brain in patients with Infantile Spasms will be evaluated with 11-C-PK11195 PET scan at the baseline and 2 weeks after the completion of ACTH treatment (given over 4 weeks), i.e., 6 weeks after the baseline PET scan.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Infantile Spasms</condition>
  <arm_group>
    <arm_group_label>Infantile Spasms</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ACTH</intervention_name>
    <description>PK PET scan before and after ACTH treatment</description>
    <arm_group_label>Infantile Spasms</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A clinical diagnosis of 'cryptogenic IS'

          -  Normal MRI

          -  No other neurological disorder

        Exclusion Criteria:

          -  Abnormal MRI

          -  No anti-inflammatory medication 48 hrs prior to PK PET scans

          -  Parent/guardian unable to give written consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Children's Hospital of Michigan</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harry T Chugani, MD</last_name>
      <phone>313-993-2605</phone>
      <email>hchugani@pet.wayne.edu</email>
    </contact>
    <investigator>
      <last_name>Ajay Kumar, MD,PhD,DNB</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Harry T Chugani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 18, 2014</lastchanged_date>
  <firstreceived_date>March 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wayne State University</investigator_affiliation>
    <investigator_full_name>Harry T Chugani</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Infantile Spasms</keyword>
  <keyword>Neuroinflammation</keyword>
  <keyword>PK11195</keyword>
  <keyword>PET</keyword>
  <keyword>ACTH</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Spasm</mesh_term>
    <mesh_term>Spasms, Infantile</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Adrenocorticotropic Hormone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
